Analyst Price Target Update on Amedica Corporation (NASDAQ:AMDA)

Amedica Corporation (NASDAQ:AMDA): The mean short term price target for Amedica Corporation (NASDAQ:AMDA) has been established at $3.75 per share. The higher price target estimate is at $5 and the lower price target estimate is expected at $3 according to 2 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $1.77

For this week, the average consensus of the company shares are rated as a Strong Buy.

On the companys insider trading activities, Lombardi Ty, officer (VP Finance) of Amedica Corp, executed a transaction worth $10,000 on September 10, 2015. A total of 25,000 shares were purchased at an average price of $0.4. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.

Amedica Corporation (NASDAQ:AMDA) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.05 points or 3.76% at $1.28 with 1,071,541 shares getting traded. Post opening the session at $1.48, the shares hit an intraday low of $1.28 and an intraday high of $1.56 and the price was in this range throughout the day. The company has a market cap of $17 million and the number of outstanding shares have been calculated to be 13,236,071 shares. The 52-week high of Amedica Corporation (NASDAQ:AMDA) is $3.62 and the 52-week low is $0.09.

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. The Companys Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Cervical and Corpectomy. In addition to its silicon nitride-based spinal fusion products, the Company markets a line of non-silicon nitride spinal fusion products, which allows it to provide surgeons and hospitals with a range of products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.